{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:28:05Z","timestamp":1771342085818,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12185-025-04101-1","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:02:50Z","timestamp":1762524170000},"page":"297-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detection of clonal selection by multicolor flow cytometry in TAM with multiple GATA1 mutations"],"prefix":"10.1007","volume":"123","author":[{"given":"Atsushi","family":"Kohso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7710-2449","authenticated-orcid":false,"given":"Shotaro","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Nannya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Toki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Hanaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Terui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"4101_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/ped.13776","volume":"61","author":"K Watanabe","year":"2019","unstructured":"Watanabe K. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome. Pediatr Int. 2019;61:222\u20139.","journal-title":"Pediatr Int"},{"key":"4101_CR2","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/s41375-021-01171-y","volume":"35","author":"G Yamato","year":"2021","unstructured":"Yamato G, Deguchi T, Terui K, Toki T, Watanabe T, Imaizumi T, et al. Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome. Leukemia. 2021;35:1480\u20134.","journal-title":"Leukemia"},{"key":"4101_CR3","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1182\/blood-2011-04-350017","volume":"118","author":"AS Gamis","year":"2011","unstructured":"Gamis AS, Alonzo TA, Gerbing RB, Hilden JM, Sorrell AD, Sharma M, et al. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the children\u2019s oncology group study A2971. Blood. 2011;118:6752\u20139.","journal-title":"Blood"},{"key":"4101_CR4","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2007-10-118810","volume":"111","author":"JH Klusmann","year":"2008","unstructured":"Klusmann JH, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008;111:2991\u20138.","journal-title":"Blood"},{"key":"4101_CR5","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","volume":"107","author":"GV Massey","year":"2006","unstructured":"Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, Taub JW, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): children\u2019s oncology group (COG) study POG-9481. Blood. 2006;107:4606\u201313.","journal-title":"Blood"},{"key":"4101_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1365-2141.2008.07231.x","volume":"142","author":"H Muramatsu","year":"2008","unstructured":"Muramatsu H, Kato K, Watanabe N, Matsumoto K, Nakamura T, Horikoshi Y, et al. Risk factors for early death in neonates with Down syndrome and transient leukaemia. Br J Haematol. 2008;142:610\u20135.","journal-title":"Br J Haematol"},{"key":"4101_CR7","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1182\/bloodadvances.2018018945","volume":"2","author":"M Flasinski","year":"2018","unstructured":"Flasinski M, Scheibke K, Zimmermann M, Creutzig U, Reinhardt K, Verwer F, et al. Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD prevention 2007 study. Blood Adv. 2018;2:1532\u201340.","journal-title":"Blood Adv"},{"key":"4101_CR8","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/ng.2759","volume":"45","author":"K Yoshida","year":"2013","unstructured":"Yoshida K, Toki T, Okuno Y, Kanezaki R, Shiraishi Y, Sato-Otsubo A, et al. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet. 2013;45:1293\u20139.","journal-title":"Nat Genet"},{"key":"4101_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/01.mph.0000212997.02554.f6","volume":"28","author":"G Xu","year":"2006","unstructured":"Xu G, Kato K, Toki T, Takahashi Y, Terui K, Ito E. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder. J Pediatr Hematol Oncol. 2006;28:696\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"4101_CR10","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1038\/s41375-021-01397-w","volume":"35","author":"T Taga","year":"2021","unstructured":"Taga T, Tanaka S, Hasegawa D, Terui K, Toki T, Iwamoto S, et al. Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome. Leukemia. 2021;35(9):3622\u20134.","journal-title":"Leukemia"},{"issue":"2","key":"4101_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.06.007","volume":"36","author":"M Labuhn","year":"2019","unstructured":"Labuhn M, Perkins K, Matzk S, Varghese L, Garnett C, Papaemmanuil E, et al. Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with down syndrome. Cancer Cell. 2019;36(2):123\u201338.","journal-title":"Cancer Cell"},{"issue":"143","key":"4101_CR12","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1182\/blood.2023022247","volume":"20","author":"T Sato","year":"2024","unstructured":"Sato T, Yoshida K, Toki T, Kanezaki R, Terui K, Saiki R, et al. Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms. Blood. 2024;20(143):2627\u201343.","journal-title":"Blood"},{"issue":"6","key":"4101_CR13","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/cancers14061583","volume":"14","author":"N Brouwer","year":"2022","unstructured":"Brouwer N, Matarraz S, Nierkens S, Hofmans M, Nov\u00e1kov\u00e1 M, da Costa ES, et al. Immunophenotypic analysis of acute megakaryoblastic leukemia: a EuroFlow study. Cancers (Basel). 2022;14(6):1583.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"4101_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/ajcp\/aqw190","volume":"146","author":"L Yin","year":"2016","unstructured":"Yin L, Lovell MA, Wilson ML, Wei Q, Liang X. Distinct GATA1 point mutations in monozygotic twins with Down syndrome and transient abnormal myelopoiesis from a triplet pregnancy: a case report and review of literature. Am J Clin Pathol. 2016;146(6):753\u20139.","journal-title":"Am J Clin Pathol"},{"issue":"22","key":"4101_CR15","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1182\/blood-2010-05-282426","volume":"116","author":"R Kanezaki","year":"2010","unstructured":"Kanezaki R, Toki T, Terui K, Xu G, Wang R, Shimada A, et al. Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia. Blood. 2010;116(22):4631\u20138.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04101-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:50:43Z","timestamp":1771339843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04101-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4101"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04101-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no potential conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}